Vitamin D-Related Disorders

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition

Volumn , Issue , 2013, Pages 613-623

  Lips, Paul ^a   van Schoor, Natasja M ^a   Bravenboer, Nathalie ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Nutritional rickets; Osteomalacia; Vitamin D intoxication; Vitamin D related disorders

Indexed keywords

EID: 84994500550     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118453926.ch75     Document Type: Chapter

References (62)

1. Parfitt AM. 2005. Vitamin D and the pathogenesis of rickets and osteomalacia. In: Feldman D, Pike JW, Glorieux FH (eds.) Vitamin D, 2nd Ed. San Diego: Elsevier Academic Press. pp. 1029-48.
2. Lips P. 2001. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22: 477-501.
3. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang YQ, Karlson EW, Dawson-Hughes B. 2004. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > = 60 y. Am J Clin Nutr 80: 752-758.
4. Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, Knol DL, Lips P. 2007. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab 92: 2058-2065.
5. Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P. 2006. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab 91: 2980-2985.
6. Nagpal S, Na S, Rathnachalam R. 2005. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 26: 662-687.
7. Norman AW. 2006. Minireview: Vitamin D receptor: New assignments for an already busy receptor. Endocrinology 147: 5542-5548.
8. Lips P. 2006. Vitamin D physiology. Prog Biophys Mol Biol 92: 4-8.
9. Peterlik M, Cross HS. 2005. Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Invest 35: 290-304.
10. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. 2001. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 358: 1500-1503.
11. Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. 2008. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev 29: 726-776.
12. Holick MF. 1994. McCollum Award Lecture, 1994: Vitamin D-New horizons for the 21st century. Am J Clin Nutr 60: 619-630.
13. Lips P. 2007. Relative value of 25(OH)D and 1,25(OH) (2)D measurements. J Bone Miner Res 22: 1668-1671.
14. Kuchuk NO, Pluijm SM, van Schoor NM, Looman CW, Smit JH, Lips P. 2009. Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 94: 1244-1250.
15. Need AG, O ' Loughlin PD, Morris HA, Coates PS, Horowitz M, Nordin BE. 2008. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res 23: 1859-1863.
16. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. 2005. Estimates of optimal vitamin D status. Osteoporos Int 16: 713-716.
17. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. 2006. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18-28.
18. Norman AW, Bouillon R, Whiting SJ, Vieth R, Lips P. 2007. 13th Workshop consensus for vitamin D nutritional guidelines. J Steroid Biochem Mol Biol 103: 204-205.
19. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. 2011. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab 96: 53-58.
20. Mansbach JM, Ginde AA, Camargo CA Jr. 2009. Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: Do children need more vitamin D? Pediatrics 124: 1404-1410.
21. Prentice A. 2008. Vitamin D deficiency: A global perspective. Nutr Rev 66: S153-S164.
22. Munns C, Zacharin MR, Rodda CP, Batch JA, Morley R, Cranswick NE, Craig ME, Cutfield WS, Hofman PL, Taylor BJ, Grover SR, Pasco JA, Burgner D, Cowell CT. 2006. Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: A consensus statement. Med J Aust 185: 268-272.
23. van der Meer IM, Karamali NS, Boeke AJP, Lips P, Middelkoop BJC, Verhoeven I, Wuister D 8 / 2006 High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am J Clin Nutr 84: 350-353.
24. Dijkstra SH, van Beek A, Janssen JW, de Vleeschouwer LH, Huysman WA, van den Akker EL. 2007. High prevalence of vitamin D deficiency in newborns of high-risk mothers. Arch Dis Child Fetal Neonatal Ed 92 (9): 750-3.
25. Lips P, van Schoor NM. 2011. Worldwide Vitamin D Status. In: Feldman D, Pike JW, Adams JS (eds.) Vitamin D, 3rd Ed., Vol. 1. San Diego: Elsevier Academic Press. pp. 947-963.
26. Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P. 2009. Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: Global perspective. J Bone Miner Res 24: 693-701.
27. Saji F, Shigematsu T, Sakaguchi T, Ohya M, Orita H, Maeda Y, Ooura M, Mima T, Negi S. 2010. Fibroblast growth factor 23 production in bone is directly regulated by 1(alpha),25-dihydroxyvitamin D, but not PTH. Am J Physiol Renal Physiol 299: F1212-F1217.
28. Christakos S, Dhawan P, Peng X, Obukhov AG, Nowycky MC, Benn BS, Zhong Y, Liu Y, Shen Q. 2007. New insights into the function and regulation of vitamin D target proteins. J Steroid Biochem Mol Biol 103: 405-410.
29. Goltzman D. 2007. Use of genetically modified mice to examine the skeletal anabolic activity of vitamin D. J Steroid Biochem Mol Biol 103: 587-591.
30. Pettifor JM. 2005. Vitamin D deficiency and nutritional rickets in children. In: Feldman D, Pike JW, Glorieux FH (eds.) Vitamin D, 2nd Ed. San Diego: Elsevier Academic Press. pp. 1065-83.
31. Lips P. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89-90: 611-614.
32. Bouillon RA, Auwerx JH, Lissens WD, Pelemans WK. 1987. Vitamin D status in the elderly: Seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr 45: 755-763.
33. Rabelink NM, Westgeest HM, Bravenboer N, Jacobs MAJM, Lips P. 2011. Bone pain and extremely low bone mineral density due to severe vitamin D deficiency in celiac disease. Arch Osteoporosis 6 (1-2): 209-213.
34. Parfitt AM, Qiu S, Rao DS. 2004. The mineralization index-A new approach to the histomorphometric appraisal of osteomalacia. Bone 35: 320-325.
35. Holick MF. 2007. Vitamin D deficiency. N Engl J Med 357: 266-281.
36. Armas LA, Hollis BW, Heaney RP. 2004. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89: 5387-5391.
37. Lips P. 2004. Which circulating level of 25-hydroxyvitamin D is appropriate? J Steroid Biochem Mol Biol 89-90: 611-614.
38. Lips P, Wiersinga A, van Ginkel FC, Jongen MJ, Netelenbos JC, Hackeng WH, Delmas PD, van der Vijgh WJ. 1988. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 67: 644-650.
39. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. 2003. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 77: 204-210.
40. Bischoff-Ferrari HA, Willett WC, Wong JB, Stuck AE, Staehelin HB, Orav EJ, Thoma A, Kiel DP, Henschkowski J. 2009. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A metaanalysis of randomized controlled trials. Arch Intern Med 169: 551-561.
41. Avenell A, Gillespie WJ, Gillespie LD, O ' Connell DL. 2005. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and postmenopausal osteoporosis. Cochrane Database Syst Rev (3): CD000227.
42. Boonen S, Lips P, Bouillon R, Bischoff-Ferrari HA, Vanderschueren D, Haentjens P. 2007. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: Evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 92: 1415-1423.
43. Visser M, Deeg DJH, Lips P. 2003. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (Sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab 88: 5766-5772.
44. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, Orav JE, Stuck AE, Theiler R, Wong JB, Egli A, Kiel DP, Henschkowski J. 2009. Fall prevention with supplemental and active forms of vitamin D: A meta-analysis of randomised controlled trials. BMJ 339: b3692.
45. Kalyani RR, Stein B, Valiyil R, Manno R, Maynard JW, Crews DC. 2010. Vitamin D treatment for the prevention of falls in older adults: Systematic review and metaanalysis. J Am Geriatr Soc 58: 1299-1310.
46. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC. 2010. Annual high-dose oral vitamin D and falls and fractures in older women: A randomized controlled trial. JAMA 303: 1815-1822.
47. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. 2011. Evaluation, treatment, and prevention of vitamin D deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 96: 1911-1930.
48. Health Council of the Netherlands. 2008. Towards an adequate intake of vitamin D. Vol. 2008/15. The Hague. http://www.gezondheidsraad.nl/en/publications/ towards-adequate-intake-vitamin-d-0.
49. Chel V, Wijnhoven HA, Smit JH, Ooms M, Lips P. 2007. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents. Osteoporos Int 19: 663-71.
50. Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SAA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O ' Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D. 2006. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354: 669-683.
51. Panda DK, Miao D, Bolivar I, Li J, Huo R, Hendy GN, Goltzman D. 2004. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem 279: 16754-16766.
52. Fraser D, Kooh SW, Kind HP, Holick MF, Tanaka Y, DeLuca HF. 1973. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D. N Engl J Med 289: 817-822.
53. Kitanaka S, Takeyama K, Murayama A, Sato T, Okumura K, Nogami M, Hasegawa Y, Niimi H, Yanagisawa J, Tanaka T, Kato S. 1998. Inactivating mutations in the 25-hydroxyvitamin D-3 1 alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 338: 653-661.
54. Glorieux FH. 1990. Calcitriol treatment in vitamin D-dependent and vitamin D-resistant rickets. Metabolism 39: 10-12.
55. Brooks MH, Bell NH, Love L, Stern PH, Orfei E, Queener SF, Hamstra AJ, DeLuca HF. 1978. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med 298: 996-999.
56. Malloy PJ, Hochberg Z, Tiosano D, Pike JW, Hughes MR, Feldman D. 1990. The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. J Clin Invest 86: 2071-2079.
57. Balsan S, Garabedian M, Larchet M, Gorski AM, Cournot G, Tau C, Bourdeau A, Silve C, Ricour C. 1986. Longterm nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D. J Clin Invest 77: 1661-1667.
58. Koutkia P, Chen TC, Holick MF. 2001. Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med 345: 66-67.
59. Vieth R, Pinto TR, Reen BS, Wong MM. 2000. Vitamin D poisoning by table sugar. Lancet 359: 672.
60. Barbour GL, Coburn JW, Slatopolsky E, Norman AW, Horst RL. 1981. Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 305: 440-443.
61. Davies M, Mawer EB, Hayes ME, Lumb GA. 1985. Abnormal vitamin D metabolism in Hodgkin's lymphoma. Lancet 1: 1186-1188.
62. Hewison M, Kantorovich V, Liker HR, Van Herle AJ, Cohan P, Zehnder D, Adams JS. 2003 Vitamin D-mediated hypercalcemia in lymphoma: Evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 18: 579-582.